These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25783671)

  • 1. A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease.
    Eaton JE; Juran BD; Atkinson EJ; Schlicht EM; Xie X; de Andrade M; Lammert CS; Luketic VA; Odin JA; Koteish AA; Kowdley KV; Chopra KB; Hirschfield GM; Chalasani NP; Lazaridis KN
    Aliment Pharmacol Ther; 2015 May; 41(10):980-90. PubMed ID: 25783671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for primary sclerosing cholangitis.
    Boonstra K; de Vries EM; van Geloven N; van Erpecum KJ; Spanier M; Poen AC; van Nieuwkerk CM; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; Beuers U; Ponsioen CY;
    Liver Int; 2016 Jan; 36(1):84-91. PubMed ID: 26077553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease.
    Okada H; Mizuno M; Yamamoto K; Tsuji T
    Acta Med Okayama; 1996 Oct; 50(5):227-35. PubMed ID: 8914675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
    Lascurain L; Jensen MK; Guthery SL; Holmen J; Deneau M
    Inflamm Bowel Dis; 2016 Jan; 22(1):146-50. PubMed ID: 26619054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
    Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
    Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis.
    Ngu JH; Gearry RB; Wright AJ; Stedman CA
    Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: environmental risk factors for PSC with and without IBD--the story unfolds.
    Assis DN; Levy C
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1214-6. PubMed ID: 25939466
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
    Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
    Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
    Bosch DE; Yeh MM
    Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue in patients with primary sclerosing cholangitis.
    Björnsson E; Simren M; Olsson R; Chapman RW
    Scand J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15513335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    J Crohns Colitis; 2014 Sep; 8(9):956-63. PubMed ID: 24559536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Sano H; Nakazawa T; Ando T; Hayashi K; Naitoh I; Okumura F; Miyabe K; Yoshida M; Takahashi S; Ohara H; Joh T
    J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):154-61. PubMed ID: 20740366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Loftus EV; Harewood GC; Loftus CG; Tremaine WJ; Harmsen WS; Zinsmeister AR; Jewell DA; Sandborn WJ
    Gut; 2005 Jan; 54(1):91-6. PubMed ID: 15591511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IBD and PSC Phenotypes of PSC-IBD.
    Ricciuto A; Kamath BM; Griffiths AM
    Curr Gastroenterol Rep; 2018 Mar; 20(4):16. PubMed ID: 29594739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment.
    Ricciuto A; Hansen BE; Ngo B; Aloi M; Walters TD; Church PC; Mazurek A; Khan M; Carman N; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1509-1517.e7. PubMed ID: 31493578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.